Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/7108
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAlimhodzhaeva L.T., Zakirova L.T., Yusupova N.B., Khodjaev A.A., Nigmanova N.A., Norbekova M.Kh., Zakhirova N.N., Abdullaeva G.D., Narzieva D.F., Shadmanova D.S.-
dc.date.accessioned2023-04-12T04:52:13Z-
dc.date.available2023-04-12T04:52:13Z-
dc.date.issued2019-
dc.identifier.issn2394-3211-
dc.identifier.urihttp://repository.tma.uz/xmlui/handle/1/7108-
dc.description.abstractRecent studies have completely changed the idea of the course of malignant diseases, in particular breast cancer (BC). For practical oncology, the addition to the conventional TNM clinical and morphological classification with the concept of four molecular biological subtypes of breast cancer has become important. Genetic classification included a variety of disease options: from luminal A, luminal B to three times negative. A completely new round of research on the biological activity of breast cancer has changed not only the clinical understanding of the process of active metastasis or its long-term latent existence in the body, but also the tactics of treatment based on the results of relapse-free and overall survival. Luminal A and three times negative variants of breast cancer are polar in many ways.en_US
dc.language.isoen_USen_US
dc.publisherEUROPEAN JOURNAL OF PHARMACEUTICAL AND MEDICAL RESEARCHen_US
dc.titleIMMUNOLOGICAL DIFFERENCES THREE NEGATIVE AND LUMINAL BREAST CANCER IN YOUNG PATIENTSen_US
dc.typeArticleen_US
Appears in Collections:Thesis, Articles

Files in This Item:
File Description SizeFormat 
European_journal_of_pharmaceutical_and_medical_research_2019,63.pdfIMMUNOLOGICAL DIFFERENCES THREE NEGATIVE AND LUMINAL BREAST CANCER IN YOUNG PATIENTS268.97 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.